Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: A potential agent for the treatment of ocular surface defects?
D Hartwig, S Harloff, L Liu, P Schlenke, T Wedel, G Geerling. Transfusion. 2004; 44(12):1724–31.
Topical treatment of ocular surface defects: Comparison of the epitheilotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in-vitro cell culture model
D Hartwig, P Herminghaus, T Wedel, L Liu, P Schlenke, L Dibbelt, G Geerling. Transfus Med. 2005;15(2):107–13.
An optimized protocol for the production of autologous serum eyedrops
L Liu, D Hartwig, S Harloff, P Herminghaus, T Wedel, G Geerling.Graefes Arch Clin Exp Ophthalmol. 2005;243(7):706–14.
Corneal epitheliotrophic capacity of three different blood-derived preparations
L Liu, D Hartwig, S Harloff, P Herminghaus, T Wedel, K Kasper, G Geerling. Invest Ophthalmol Vis Sci. 2006;47(6):2438–44.
Immunological responses in mice to full-thickness corneal grafts engineered from porcine collagen
L Liu, L Kuffova, M Griffith, Z Dang, El Muckersie, Y Liu, CR McLaughlin, JV Forrester. Biomaterials. 2007;28(26):3807–14.
Nourish and nurture-development of a nutrient ocular lubricant
L Liu, JM Tiffany, Z Dang, JKG Dart, SL Watson, D Hartwig,
G Geerling. Invest Ophthalmol Vis Sci. 2009;50(6):2932–9.
Generation of two- and three-dimensional lacrimal gland constructs
S Schrader, L Liu, K Kasper, G Geerling. Dev Ophthalmol. 2010;45:49–56.
Soluble antigen traffics rapidly and selectively from the corneal surface to the eye draining lymph node and activates T cells when codelivered with CpG oligonucleotides
Z Dang, L Kuffová, L Liu, JV Forrester. J Leukoc Biol. 2014;95(3):431–40.
Cortisol biosynthesis in the human ocular surface innate immune response
R Susarla (first author), L Liu (first author), E A Walker, I J. Bujalska, Jr Al-Salem, G P Williams, S Sreekantam, A E. Taylor, M Tallouzi, H. S Southwood, P I. Murray, G R. Wallace, and S Rauz. PLoS One. 2014 15;9(4):e94913.
TLR9 agonist regulates angiogenesis and inhibits corneal neovascularization
J Wu, H Cui, A Dick, L Liu. Am J Pathol. 2014;184(6):1900–10. doi: 10.1016/j.ajpath.2014.03.001.
Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways
J Wu, W Su, M Powner, J Liu, D Copland, M Fruttiger, P Maddedu, A Dick, and L Liu. Scientific Report. 2016 Aug 25;6:31873. doi: 10.1038/srep31873.